ONEMEDNET CORPORATION Operating Income
ONEMEDNET CORPORATION (ONMD) reported Operating Income of -$2.26 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-14
- ONEMEDNET CORPORATION operating income (loss) for the quarter ending 2026-06-30 was -$2.26M.
- ONEMEDNET CORPORATION operating income (loss) for the quarter ending 2026-03-31 was -$2.55M.
- ONEMEDNET CORPORATION operating income (loss) for the quarter ending 2025-12-31 was -$3.08M.
- ONEMEDNET CORPORATION operating income (loss) for the quarter ending 2025-09-30 was -$2.23M.
- ONEMEDNET CORPORATION operating income (loss) for fiscal 2023 was -$6.85M.
- ONEMEDNET CORPORATION operating income (loss) for fiscal 2022 was -$7.71M.
| Period end | Operating Income (Loss) 2 month | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 5 month | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 8 month | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 11 month | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.26M 10-Q · filed 2026-08-14 | -$4.81M 10-Q · filed 2026-08-14 | -$7.89M derived: sum of 3 quarters · filed 2026-08-14 | -$10.13M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||
| 2026-03-31 | -$2.55M S-1/A · filed 2026-07-08 | -$5.63M derived: sum of 2 quarters · filed 2026-07-08 | -$7.87M derived: sum of 3 quarters · filed 2026-07-08 | -$9.93M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||
| 2025-12-31 | -$3.08M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | -$5.32M derived: sum of 2 quarters · filed 2026-07-08 | -$7.38M derived: sum of 3 quarters · filed 2026-08-14 | -$9.67M S-1/A · filed 2026-07-08 | ||||||||
| 2025-09-30 | -$2.23M 10-Q · filed 2025-11-14 | -$4.30M derived: sum of 2 quarters · filed 2026-08-14 | -$6.58M 10-Q · filed 2025-11-14 | -$9.24M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||
| 2025-06-30 | -$2.06M 10-Q · filed 2026-08-14 | -$4.35M 10-Q · filed 2026-08-14 | -$7.00M derived: sum of 3 quarters · filed 2026-08-14 | -$9.34M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||
| 2025-03-31 | -$2.22M S-1/A · filed 2026-07-08 | -$4.94M derived: sum of 2 quarters · filed 2026-07-08 | -$7.28M derived: sum of 3 quarters · filed 2026-07-08 | -$9.73M derived: sum of 4 quarters · filed 2026-07-08 | ||||||||
| 2024-12-31 | -$2.72M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | -$5.05M derived: sum of 2 quarters · filed 2026-07-08 | -$7.51M derived: sum of 3 quarters · filed 2026-07-08 | -$9.61M S-1/A · filed 2026-07-08 | ||||||||
| 2024-09-30 | -$2.34M 10-Q · filed 2025-11-14 | -$2.39M 10-Q · filed 2024-12-17 | -$4.79M derived: sum of 2 quarters · filed 2025-11-14 | -$6.89M 10-Q · filed 2025-11-14 | -$6.94M 10-Q · filed 2024-12-17 | -$8.76M derived: sum of 4 quarters · filed 2025-11-14 | ||||||
| 2024-06-30 | -$2.45M 10-Q · filed 2025-08-13 | -$4.55M 10-Q · filed 2025-08-13 | -$6.42M derived: sum of 3 quarters · filed 2025-08-13 | -$8.35M derived: sum of 4 quarters · filed 2025-08-13 | ||||||||
| 2024-03-31 | -$2.10M 10-Q · filed 2025-05-14 | -$3.97M derived: sum of 2 quarters · filed 2025-05-14 | -$5.90M derived: sum of 3 quarters · filed 2025-05-14 | -$7.47M derived: sum of 4 quarters · filed 2025-05-14 | ||||||||
| 2023-12-31 | -$1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$3.79M derived: sum of 2 quarters · filed 2025-04-15 | -$5.37M derived: sum of 3 quarters · filed 2025-04-15 | -$6.85M 10-K · filed 2025-04-15 | -$8.37M 10-K · filed 2024-04-09 | |||||||
| 2023-09-30 | -$1.93M 10-Q · filed 2024-12-17 | -$918.48K 10-Q/A · filed 2023-12-18 | -$3.50M derived: sum of 2 quarters · filed 2024-12-17 | -$4.99M 10-Q · filed 2024-12-17 | -$4.41M 10-Q · filed 2023-11-20 | -$6.84M derived: sum of 4 quarters · filed 2024-12-17 | ||||||
| 2023-06-30 | -$1.57M 10-Q · filed 2024-12-11 | -$285.45K 10-Q · filed 2023-08-14 | -$3.06M 10-Q · filed 2024-12-11 | -$639.24K 10-Q · filed 2023-08-14 | -$4.91M derived: sum of 3 quarters · filed 2024-12-11 | -$7.85M derived: sum of 4 quarters · filed 2024-12-11 | ||||||
| 2023-03-31 | -$1.47M 10-Q · filed 2024-12-05 | -$353.78K 10-Q · filed 2023-05-19 | -$3.34M derived: sum of 2 quarters · filed 2024-12-05 | -$6.28M derived: sum of 3 quarters · filed 2024-12-05 | -$7.08M derived: sum of 4 quarters · filed 2024-12-05 | |||||||
| 2022-12-31 | -$1.87M derived: 10-K/A 12 month − 8-K/A 9 month · filed 2024-11-05 | -$4.81M derived: sum of 2 quarters · filed 2024-11-22 | -$5.61M derived: sum of 3 quarters · filed 2024-11-22 | -$7.71M 10-K/A · filed 2024-11-05 | -$5.31M 10-K · filed 2023-03-31 | |||||||
| 2022-09-30 | -$2.94M 8-K/A · filed 2024-11-22 | -$520.02K 10-Q · filed 2022-11-18 | -$3.74M derived: sum of 2 quarters · filed 2024-11-22 | -$5.84M 8-K/A · filed 2024-11-22 | -$1.92M 10-Q · filed 2022-11-18 | |||||||
| 2022-06-30 | -$794.50K 10-Q · filed 2023-08-14 | -$1.40M 10-Q · filed 2023-08-14 | ||||||||||
| 2022-03-31 | -$610.18K 10-Q · filed 2023-05-19 | |||||||||||
| 2021-12-31 | -$585.40K 10-K · filed 2023-03-31 | |||||||||||
| 2021-09-30 | -$98.72K 10-Q · filed 2022-11-18 | -$169.22K derived: sum of 2 quarters · filed 2022-11-18 | -$170.06K 10-Q · filed 2022-11-18 | |||||||||
| 2021-06-30 | -$70.49K 10-Q · filed 2022-08-15 | -$70.50K 10-Q · filed 2021-08-16 | -$71.34K 10-Q · filed 2022-08-15 | |||||||||
| 2021-03-31 | -$845.00 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |